RxDoctor Payments Data

Philip Landry, MD

Psychiatry · Opelousas, LANPI 1639218738

Payments from drug & device makers

$935in general payments, 2019–2025

Across 52 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$360
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$99
  • Acadia Pharmaceuticals Inc$74
  • Teva Pharmaceuticals USA, Inc.$71
  • Takeda Pharmaceuticals U.S.A., Inc.$69
  • Alkermes, Inc.$51
  • plus $211 from 8 others

What the payments were for

  • Food & beverage$935100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$935 in reported general payments places this provider in the 60th percentile of 474 psychiatry providers in Louisiana.

See all psychiatry providers in Louisiana

Medicare billing

Part B allowed, 2024
$57,597
Medicare patients
102
Services billed
594

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate11$38,445
VraylarCariprazine Hcl25$35,874
Paliperidone ErPaliperidone33$3,559
Aripiprazole71$3,089
Lurasidone Hcl41$2,852
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine63$2,825
Divalproex Sodium ErDivalproex Sodium59$2,001
Chlorpromazine Hcl11$1,993
Quetiapine Fumarate146$1,738
Haloperidol34$1,545
Ziprasidone Hcl51$1,503
Clonazepam173$1,302
Bupropion XlBupropion Hcl49$1,185
Divalproex Sodium26$905
Alprazolam98$900

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$30$38,44511 claims
AbbVieVraylar$360$35,87425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 474 psychiatry providers in Louisiana.

Other psychiatry in Opelousas

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →